Dxcover’s Head of Product & Business Development, Alisa Tubbs, will be attending the Women’s Health Innovation Summit 2026 in Boston next month.
Get in touch with us to schedule a meeting!
#WHIS2026#WomenHealth#Innovation#Networking#GynecologicCancers
Dxcover’s CEO will be attending Tech Tour Mental & Brain Health 2026 in Glasgow next week.
We are looking forward to connecting with investors and innovators to exchange ideas and build new relationships!
#TechTour#BrainHealth#Networking#HealthTech#Innovation
September is #GynecologicalCancerAwarenessMonth and we highlight the importance of developing new approaches to #EarlyDetection.
#OvarianCancer remains one of the most challenging cancers to identify early, yet Dxcover's blood-based platform showed 93% sensitivity in stage I!
Focusing on solutions on #WorldLungCancerDay🫁💡The #Dxcover blood-based testing platform presents a quick turnaround test that is highly sensitive at all stages, supporting screening & improving compliance. Together we can detect cancer earlier and see better patients outcomes!
Abigail is joining the All Party Parliamentary Group (#appg) for a session on #LessSurvivableCancers.
The @LessSurvivable focuses on patients affected by cancers of the brain, liver, lungs, pancreas, oesophagus, and stomach and advocates for action to improve survival rates.
#UterineCancer is the most common #Gynecologic cancer in the US and UK, and the n. of cases is expected to increase by 50% by 2045*
June is #UterineCancerAwarenessMonth, a timely reminder of raising awareness to support earlier diagnosis and improve outcomes.
*IARC & #IGCS#UCAM
#ASCO26 highlighted new therapies that demonstrate impressive improvements in median overall survival for #pancreatic and #ovarian#cancer patients. What might be possible if more patients could benefit from breakthroughs at earlier stages thanks to earlier detection? #MedTech
On #WorldBrainTumorDay, we stand with everyone affected by a #BrainCancer diagnosis, remember those we have lost, and acknowledge the dedication of researchers. Dxcover is proud to work towards #EarlyDetection with the UKCA and CE-IVDR marked Brain Cancer Liquid Biopsy test.